Certified by Founder Lodge
Sable Bio
United Kingdom - London
START UP
1 Disclosed Funding Rounds $1,883,707
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Prevent target safety failures with unique data insights and cutting-edge approaches.
Better prediction of drug safety could help patients and prevent hugely costly trial failures. Our ad
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 06 ,2024 | Pre-Seed | $1,883,707 |
Episode 1 Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
UPTIQ | $12,000,000 | (Oct 29, 2025)
Flamingo(US) | $2,200,000 | (Oct 29, 2025)
Spacial | $10,000,000 | (Oct 29, 2025)
Cylerity | $4,000,000 | (Oct 29, 2025)
Syllo | $30,000,000 | (Oct 29, 2025)
